PARTIAL OSSICULAR REPLACEMENT PROSTHESIS (PORP) by MEDNET LOCATOR, INC.

The MedNet Locator, INC., Partial Ossicular Replacement Prosthesis (PORP) is to be used by ear, nose and throat physicians to restore the hearing mechanism related to loss or destruction or damage to the ear ossicles due to prolonged chronic infection.

Device Description

Partial Ossicular Replacement Prosthesis (PORP)

AI/ML Overview

The provided text is an FDA 510(k) clearance letter for a medical device: "Partial Ossicular Replacement Prosthesis (PORP)". This type of document declares substantial equivalence to a predicate device, allowing it to be marketed. It does not contain information about acceptance criteria or a study that proves the device meets specific performance criteria.

Therefore, I cannot provide the requested information. The 510(k) process primarily focuses on demonstrating that a new device is as safe and effective as a legally marketed predicate device, rather than requiring extensive de novo performance studies with acceptance criteria as might be seen for novel technologies or PMA applications.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows a logo for the Department of Health and Human Services. The logo consists of a stylized depiction of an abstract human figure with three wavy lines representing the hair or head. The text "DEPARTMENT OF HEALTH &" is arranged vertically along the left side of the logo, curving to follow the shape of the emblem.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Judy S. Chandler MedNet Locator, Inc. 7000 Shadow Oaks Memphis, TN 38125 Re: K972734 Partial Ossicular Replacement Prosthesis Dated: July 16, 1997 Received: July 22, 1997 Regulatory Class: II 21 CFR 874.3450/Procode: 77 ETB

SEP - 5 1997

Dear Ms. Chandler:

We have reviewed your Section 510(k) notification of intent to market the device and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Tile 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for question and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours.

h.J.Liau Yin
Lillian Yin, Ph.D.

Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{1}------------------------------------------------

Page 1 of of ------

510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

Device Name:_Partial Ossicular Replacement Prosthesis (PORP)

Indications For Use:

ﯽ ﺗ

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Rume mctive, Redonneal, ENT, and Radiolomeai
510(k) Number	K972734

Prescription Use_	OR	Over-The-Counter Use_
(Per 21 CFR 801.109)

(Optional Format 1-2-96)

Regulation Number and Section

§ 874.3450 Partial ossicular replacement prosthesis.

(a)
Identification. A partial ossicular replacement prosthesis is a device intended to be implanted for the functional reconstruction of segments of the ossicular chain and facilitates the conduction of sound wave from the tympanic membrane to the inner ear. The device is made of materials such as stainless steel, tantalum, polytetrafluoroethylene, polyethylene, polytetrafluoroethylene with carbon fibers composite, absorbable gelatin material, porous polyethylene, or from a combination of these materials.(b)
Classification. Class II.